Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 970 participants.
Also called NCT01502774
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 970 participants
- Sponsor
- Registry
-
NCT01502774
-
- Other papers using this trial's data
- Cyclosporine before PCI in Patients with Acute Myocardial Infarction
- Importance of infarct size versus other variables for clinical outcomes after PPCI in STEMI patients
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- Belgium, France, Spain
- Registry status
- Completed
Technical summary
Registry record NCT01502774. Randomized; quadruple masking; primary purpose treatment. Start 2011-04 (registry gives no type); primary completion 2015-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Cyclosporine and Prognosis in Acute Myocardial Infarction (MI) Patients
- Acronym
- CIRCUS
- Condition
- ST Elevation Acute Myocardial Infarction
- Intervention (Drug)
- Injection of Cyclosporin
- Intervention (Drug)
- Placebo
- Intervention (Procedure)
- Echocardiography
- Lead sponsor
- Hospices Civils de Lyon
Record details
- Record id
cardio:ct-nct01502774- Content hash
c7237746d77254ddb5f613a959a1588ad15fe00a3cbd79fb132175e32e093beb